COMMUNIQUÉS West-GlobeNewswire

Chiesi and Holostem Announce FDA Orphan Drug Designation for GPLSCD01 for treatment of Limbal Stem Cell Deficiency (LSCD)
12/06/2018
Investigational therapy uses individual patient’s own stem cells to potentially regenerate and repair damaged eye tissue CARY, N.C., June 12, 2018 (GLOBE NEWSWIRE) -- Chiesi USA (key-A-zee) , a specialty pharmaceutical [...]
resTORbio Announces Appointment of Kerry Russell, M.D., Ph.D., as Vice President of Clinical Development
12/06/2018
Newly Created Position Strategically Expands Development Capabilities BOSTON, June 12, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ:TORC) today announced that Kerry Russell, M.D., Ph.D., has joined the company as [...]
Progressive Care Launches Opioid Alternative Treatment Campaign Aimed at Reaching Millions Affected by the Nationwide Epidemic
12/06/2018
MIAMI, June 12, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a personalized healthcare services and technology company, today launched a new program designed to educate patients and providers on [...]
GeneDx Announces Completion of 100,000 Exome Sequences
12/06/2018
Milestone achievement offers significant contribution to clinically relevant genetic variants used to diagnose rare and genetic diseases GAITHERSBURG, Md., June 12, 2018 (GLOBE NEWSWIRE) -- GeneDx, Inc., a subsidiary of [...]
Cambrex Expands Generic API Research and Development Capabilities at Milan, Italy Site
12/06/2018
EAST RUTHERFORD, N.J., June 12, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that it [...]
Nu-Med Plus, Inc. engages Millennium Biosciences for Quality and Regulatory consulting services
12/06/2018
SALT LAKE CITY, June 12, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB:NUMD), a medical device company which investigates and develops applications of Nitric Oxide technologies in the medical field, has selected [...]
Matinas BioPharma to Present at the 20th ICHS Symposium on Infections in the Immunocompromised Host
12/06/2018
BEDMINSTER, N.J., June 12, 2018 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER:MTNB), a clinical-stage biopharmaceutical company focused on enabling the delivery of life-changing medicines using its [...]
Opiant Pharmaceuticals Appoints Biotech and Pharmaceutical Industry Veteran Richard Daly to Board of Directors
12/06/2018
SANTA MONICA, Calif., June 12, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. ("Opiant") (NASDAQ:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions, today announced the [...]
Cancer Genetics Strengthens Management Team with Appointment of Michael McCartney as Chief Commercial Officer
12/06/2018
Executive appointment underscores continued execution of new corporate strategy of expanding Biopharma and Discovery businesses RUTHERFORD, N.J., June 12, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a [...]
Lotus Purchases 23-Acre Cannabis Facility Site in Armstrong BC
12/06/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, June 12, 2018 (GLOBE NEWSWIRE) -- Lotus Ventures Inc. (CSE:J) has exercised the option to purchase [...]
Precipio Reminds Shareholders to Vote Before the Annual General Meeting on June 15, 2018
12/06/2018
NEW HAVEN, Conn., June 12, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), today reminded its shareholders to vote on proposals 1-6 in accordance with the recommendations of the [...]
OncoMed Doses First Patient in Phase 1b Portion of anti-TIGIT Clinical Trial
12/06/2018
Expanded Phase of Trial will Assess anti-TIGIT in Combination with anti-PD1 REDWOOD CITY, Calif., June 12, 2018 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals Inc. (NASDAQ:OMED), a clinical-stage biopharmaceutical company [...]
Bellerophon Therapeutics to Participate on Panel at JMP Securities Life Sciences Conference
12/06/2018
WARREN, N.J., June 12, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today announced that it will participate on a [...]
Tyme Releases Detailed Data and Analyses with SM-88 From the First Human Study and Compassionate Use Programs
12/06/2018
NEW YORK, June 12, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ:TYME), a clinical-stage biotechnology company developing cancer therapeutics, today release detailed patient data and analyses from both the [...]
Akcea and Ambry Genetics to Launch hATTR Compass, a Genetic Testing Program for People with Suspected Hereditary ATTR Amyloidosis
12/06/2018
hATTR Compass to provide no-cost, confidential genetic testing and genetic counseling services, potentially enabling faster diagnosis CAMBRIDGE, Mass., June 12, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (Nasdaq: [...]
Online Sales Climb to $669,000 in May, Driving May Revenues 639% Above 2017 for PotNetwork Holdings, Inc.'s Diamond CBD
12/06/2018
With Over a $100,000 in Orders in The Final 5 Days of May,Year Over Year Gains Continue To Build Momentum FT LAUDERDALE, Fla., June 12, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- PotNetwork Holdings, Inc. (OTC Pink: [...]
Moleculin Targets accelerated FDA approval of WP1732; Pursues Development for Ocular Tumors
12/06/2018
HOUSTON, June 12, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. (Nasdaq:MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of [...]
Idera Pharmaceuticals Reports Results from Phase 2 Trial of IMO-8400 in Dermatomyositis
12/06/2018
Clinical trial did not meet primary endpoint of statistically significant reduction of CDASI for IMO-8400 versus placebo EXTON, Pa., June 12, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a [...]
Avalon GloboCare Forms Joint Venture with Jiangsu Unicorn to Establish Provincial Network of Translational Cellular Therapy and Bio-Banking Programs
12/06/2018
FREEHOLD, N.J., June 12, 2018 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (OTCQB:AVCO), a leading global developer of cell-based technologies, announced today that the Company has formed a joint venture with Jiangsu [...]

Pages